🔎 Trials Near Me

Hjem › Type 2-diabetes › Louisiana

Type 2-diabetes kliniske forsøg i Louisiana

15 studier for Type 2-diabetes søger deltagere på steder i Louisiana.

Byer i Louisiana

Officiel studietekst (engelsk)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Grace Research, LLC-Bossier City-51040, Bossier City
  • Louisiana Heart Center - Covington, Covington
  • IMA Clinical Research Monroe, Monroe
  • og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Ascension DePaul Services Research Center, New Orleans
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
  • IMA Clinical Research Monroe - Armand, Monroe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Monroe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Baton Rouge
  • AURORA-2 Clinical Site, Metairie
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Elevate Clinical Research, Lake Charles
  • Nola Care Clinical Research Center, Metairie
  • DelRicht Clinical Research, LLC, New Orleans
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • IMA Clinical Research, Monroe
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Lafayette, Lafayette
  • NOLA Care Clinical Research, Metairie
  • Tulane University School of Medicine, New Orleans
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484

Enhancing Diabetes Care by Treating Insomnia

  • Southeast Community Health Systems, Zachary
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07062406

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Zachary
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109

Continuous Glucose Monitoring (CGM) in an Underserved Population

  • University Medical Center, New Orleans
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 5. maj 2026 · NCT07135531

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • Tandem Clinical Research (Interspond), Marrero
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07546929

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

  • Poirot Podiatry, Metairie
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. dec. 2024 · NCT06674980

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.